Literature DB >> 22364273

Phylogenetic distribution of genes encoding β-glucuronidase activity in human colonic bacteria and the impact of diet on faecal glycosidase activities.

Freda M McIntosh1, Nathalie Maison, Grietje Holtrop, Pauline Young, Valerie J Stevens, Jennifer Ince, Alexandra M Johnstone, Gerald E Lobley, Harry J Flint, Petra Louis.   

Abstract

Bacterial β-glucuronidase in the human colon plays an important role in cleaving liver conjugates of dietary compounds and xenobiotics, while other glycosidase activities are involved in the conversion of dietary plant glycosides. Here we detected an increase in β-glucuronidase activity in faecal samples from obese volunteers following a high-protein moderate carbohydrate weight-loss diet, compared with a weight maintenance diet, but little or no changes were observed when the type of fermentable carbohydrate was varied. Other faecal glycosidase activities showed little or no change over a fivefold range of dietary NSP intake, although α-glucosidase increased on a resistant starch-enriched diet. Two distinct groups of gene, gus and BG, have been reported to encode β-glucuronidase activity among human colonic bacteria. Degenerate primers were designed against these genes. Overall, Firmicutes were found to account for 96% of amplified gus sequences, with three operational taxonomic units particularly abundant, whereas 59% of amplified BG sequences belonged to Bacteroidetes and 41% to Firmicutes. A similar distribution of operational taxonomic units was found in a published metagenome dataset involving a larger number of volunteers. Seven cultured isolates of human colonic bacteria that carried only the BG gene gave relatively low β-glucuronidase activity that was not induced by 4-nitrophenyl-β-D-glucuronide. By comparison, in three of five isolates that possessed only the gus gene, β-glucuronidase activity was induced.
© 2012 Society for Applied Microbiology and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22364273     DOI: 10.1111/j.1462-2920.2012.02711.x

Source DB:  PubMed          Journal:  Environ Microbiol        ISSN: 1462-2912            Impact factor:   5.491


  33 in total

Review 1.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

Review 2.  The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.

Authors:  Maryann Kwa; Claudia S Plottel; Martin J Blaser; Sylvia Adams
Journal:  J Natl Cancer Inst       Date:  2016-04-22       Impact factor: 13.506

Review 3.  The role of the gut microbiota in nutrition and health.

Authors:  Harry J Flint; Karen P Scott; Petra Louis; Sylvia H Duncan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-09-04       Impact factor: 46.802

Review 4.  The gut microbiota, bacterial metabolites and colorectal cancer.

Authors:  Petra Louis; Georgina L Hold; Harry J Flint
Journal:  Nat Rev Microbiol       Date:  2014-09-08       Impact factor: 60.633

Review 5.  Allergic Inflammation: Effect of Propolis and Its Flavonoids.

Authors:  Nada Oršolić
Journal:  Molecules       Date:  2022-10-08       Impact factor: 4.927

6.  Decreased Tissue Omega-6/Omega-3 Fatty Acid Ratio Prevents Chemotherapy-Induced Gastrointestinal Toxicity Associated with Alterations of Gut Microbiome.

Authors:  Kanakaraju Kaliannan; Shane O Donnell; Kiera Murphy; Catherine Stanton; Chao Kang; Bin Wang; Xiang-Yong Li; Atul K Bhan; Jing X Kang
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

7.  Phylogenetic distribution of three pathways for propionate production within the human gut microbiota.

Authors:  Nicole Reichardt; Sylvia H Duncan; Pauline Young; Alvaro Belenguer; Carol McWilliam Leitch; Karen P Scott; Harry J Flint; Petra Louis
Journal:  ISME J       Date:  2014-02-20       Impact factor: 10.302

Review 8.  Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.

Authors:  Alexander J Prokopienko; Thomas D Nolin
Journal:  Expert Rev Clin Pharmacol       Date:  2017-09-20       Impact factor: 5.045

9.  The human fecal microbiota metabolizes deoxynivalenol and deoxynivalenol-3-glucoside and may be responsible for urinary deepoxy-deoxynivalenol.

Authors:  Silvia W Gratz; Gary Duncan; Anthony J Richardson
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

10.  Association of fecal microbial diversity and taxonomy with selected enzymatic functions.

Authors:  Roberto Flores; Jianxin Shi; Mitchell H Gail; Pawel Gajer; Jacques Ravel; James J Goedert
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.